Audience Question Call-out: Was FDA Right To Reject MDMA Therapy For PTSD?
Hi everyone,
Today, I’m recording a very important debate/discussion with my friend Matt Johnson — notable psychedelic research formerly at Johns Hopkins (most famous for “mystical experience” studies on psilocybin — and Kim Witczak, a previous guest on the show and member of the FDA Advisory Committee.
Kim voted against the approval of MDMA therapy as part of the Committee, while Matt is of the opinion it should’ve been approved, despite some valid concerns raised in the advisory meeting.
For those of you who may not have followed, the FDA sided with Advisory Committee’s decision and rejected approval of MDMA therapy last week.
This will be a crucial conversation on this topic and we would like to field any questions or concerns you may have.
Please leave it in the comments below and we will try to answer as many as possible!
Johnathan Edwards here, author of The Revolutionary Ketamine. My question is did the people at the FDA meeting consider that we are losing about 40 veterans per day to suicide. We used to think it was 20 per day. New data suggest the former. Also, this dark statistic doesn't even touch the number of veterans suffering from PTSD which seems to be better treated with MDMA versus ketamine or other psychedelics. Thank you. Johnathan Edwards MD
The FDA has no credibility when it comes to what they do and don't approve. They are not 'protecting people' with any of their decisions. Look at the mRNA disaster.
Taking psychodelics or MDMA under supervision of a doctor or 'spirit guide' or someone sober is being responsible. If you have ever been to a concert you have been around people doing many illegal drugs and for the most part they coexist without problems. They have no business restricting therapy that you could get at a concert.